DPZ vs LYRA · P/E 26, rev $1.19B vs rev $1.5M
Domino's Pizza Inc Common Stock (DPZ) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Domino's Pizza Inc Common Stock (DPZ) is a restaurants company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported DPZ revenue for 2026-06-14 was $1.19B. Net income was $135.8M. Revenue was up 3.8% from 2026-03-22 to 2026-06-14. DPZ currently screens at market cap $15.57B and trailing P/E 26.0.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
DPZ currently screens at market cap $15.57B and trailing P/E 26.0. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the DPZ and LYRA stock pages for the full models.
Not investment advice.